OREXIGEN THERAPEUTICS INC - NOTE 2.750%12/0

CUSIP: 686164AB0

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Debt / NOTE 2.750%12/0
Market price (% of par)
47.0%
Total 13F principal
$22,560,000
Principal change
+$100,000
Total reported market value
$10,147,000
Number of holders
4
Value change
-$209,000
Number of buys
2
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 686164AB0?
CUSIP 686164AB0 identifies 686164AB0 - OREXIGEN THERAPEUTICS INC - NOTE 2.750%12/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OREXIGEN THERAPEUTICS INC - NOTE 2.750%12/0 as of Q3 2017

As of 30 Sep 2017, OREXIGEN THERAPEUTICS INC - NOTE 2.750%12/0 was held by 4 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $22,560,000 in principal (par value) of the bond. The largest 4 bondholders included BVF INC/IL, UBS OCONNOR LLC, GLG LLC, and BANK OF AMERICA CORP /DE/. This page lists 4 institutional bondholders reporting positions for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.